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Caspase-3 (CASP3) cleaves many proteins including protein kinases (PKs). Understanding the relationship(s) between CASP3
anditsPKsubstratesisnecessarytodelineatetheapoptosissignalingcascadesthatarecontrolledbyCASP3activity.Wereport
herein the characterization of a CASP3-substrate kinome using a simple cell-free system to synthesize a library that contained
304 PKs tagged at their N- and C-termini (NCtagged PKs) and a luminescence assay to report CASP3 cleavage events.
Forty-three PKs, including 30 newly identiﬁed PKs, were found to be CASP3 substrates, and 28 cleavage sites in 23 PKs were
determined. Interestingly, 16 out of the 23 PKs have cleavage sites within 60 residues of their N- or C-termini. Furthermore, 29 of
the PKs were cleaved in apoptotic cells, including ﬁve that were cleaved near their termini in vitro. In total, approximately 14% of
the PKs tested were CASP3 substrates, suggesting that CASP3 cleavage of PKs may be a signature event in apoptotic-signaling
cascades. This proteolytic assay method would identify other protease substrates.
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Subject Category: Immunity
On the basis of the corresponding genetic sequences, 4500
humanandmouseproteolyticenzymeshavebeenpredicted.
1
This number is comparable with that found for protein kinases
(PKs), which are the main signal-transduction enzymes.
2,3
Proteases are involved in the maturation, localization,
stabilization, and complex formation of proteins, and in many
biological processes, for example, normal development,
4,5
cancer,
6,7 infectious diseases,
8 and cell death.
9 Therefore,
it is important to be able to identify protease substrates
using simple assays.
Apoptosisrequirestheaction ofmanydifferentproteins that
participate in apoptotic cell-signaling pathways.
10 Caspases
and PKs are critical components of growth and apoptosis
signaling pathways.
2,10 Large-scale analyses of the biological
networks involving PKs and caspases are vital for the eluci-
dation of apoptosis signaling pathways. Recent whole-cell
proteomic studies that used mass spectrometry attempted to
identify substrates of caspases that are involved in apoptosis
and have shown thatthe percentage of PKs found as caspase
substrates during apoptosis is 3–6% of B300.
11,12 However,
cellular protein expression levels may have biased the
results.
13 Furthermore, it is difﬁcult to identify speciﬁc pairs
of proteases and substrates because numerous cleavage
events occur simultaneously in cells. Therefore, an in vitro
approach that could identify speciﬁc proteases and their
corresponding substrates would complement cell-based
approaches. A diagram, derived from a comprehensive
in vitro study, that illustrates the relationships between
caspases and their PK substrates would help clarify the
signal-transduction events that occur during apoptosis.
A collection of recombinant proteins, that is, a protein
library, is needed to screen a large number of protein
substrates. In addition, to screen a protein library compre-
hensively two in vitro high-throughput methods – one for
protein synthesis and one for the detection of the targeted
biochemical reaction – are required. Recently, we developed
an automated protein synthesis system that uses a wheat
cell-free system.
14–16 Using this system, we were able to
synthesize many human and Arabidopsis PKs.
17,18 Recent
work by others suggested that the wheat cell-free system
could produce 13364 human proteins, which, because of
the large number of proteins involved, represents an in vitro-
expressed proteome.
19 We also recently developed a method
to label monobiotin proteins that had been synthesized in the
wheat cell-free system.
20 These monobiotin-labeled proteins
were then used directly – without puriﬁcation – to detect
protein ubiquitination
21 and an autoantibody in the serum.
22
As the procedures used with many commercially available
detection kits depend on biotin–streptavidin interactions, our
puriﬁcation-free, synthesis/biotin-labeling method provides
a simple and highly speciﬁc system that can be used for
biochemical analyses.
Caspase-3 (CASP3) cleaves many different proteins,
23,24
and its action in vivo irreversibly induces apoptosis. For
the study reported herein, we delineated a CASP3-substrate
kinome using a simple luminescent-based detection method
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www.nature.com/cddisto screen an N- and C-terminally tagged (NCtagged) PK
library produced in the wheat cell-free system. This compre-
hensive characterization of a CASP3-substrate kinome is a
resource that can be used to understand the roles of PKs in
apoptosis.
Results
Generation of an NCtagged PK library used to identify
CASP3 PK substrates. To identify PKs that are substrates
of CASP3, we ﬁrst made a library consisting of 248 human
and 56 mouse PKs (Supplementary Table S1). The nucleo-
tide sequences for the Flag-tag and the biotin ligation site
(bls) were added upstream and downstream, respectively, of
the PK open-reading frame by PCR incorporation of Gateway
recombination tags. Each PCR product (attB1-Flag-PK-
bls-attB2) was inserted into a pDONR221 vector using the
Gateway BP Clonase II system (upper panel, Figure 1). The
Flag-PK-bls nucleotide sequences from the Escherichia coli
cultures were used without puriﬁcation to construct, by split-
primer PCR, the DNA templates for protein synthesis.
14 The
NCtagged PK library (304 PKs) was produced using an
automated protein synthesizer (GenDecoder 1000; CellFree
Sciences Co., Ltd., Matsuyama, Japan), with biotin and biotin
ligase added into the synthesis mixtures for monobiotin
labeling at the bls.
20,21 That the members of the protein
library were NCtagged was conﬁrmed by immunoblotting
with anti-Flag antibodies and Alexa488-labeled streptavidin.
To assess the suitability of the designed PKs to act
as CASP3 substrates, we used NCtagged p21-activated
kinase 2 (PAK2), which is a known CASP3 substrate,
25 as
the test case. The biotinylated NCtagged-PAK2 (Flag-PAK2-
blsBbiotin) was treated with CASP3 and cleavage of PAK2
was conﬁrmed by immunoblotting with Alexa488-conjugated
streptavidin (Figure 2a). In addition, the cleavage site
(319DELDkS323), determined by amino-acid sequencing,
was found to be the same as that reported previously.
25
(The arrow indicates the hydrolytic bond.)
A luminescent assay to detect PK substrates of
CASP3. A schematic of the assay used to monitor
cleavage of the NCtagged PKs by CASP3 is shown in
Figure 1. The PK construct is ﬁrst incubated with CASP3. If
the construct contains a sequence that can be cleaved by
CASP3, cleavage occurs. Acceptor and donor beads are
then added. The Flag-tag binds a protein A-conjugated
acceptor bead via an anti-Flag antibody, and the biotin bound
to the C-terminus of the PK construct binds a streptavidin-
conjugated donor bead. If an acceptor bead is in close
contact with the donor bead, as is the case when the
construct is not a CASP3 substrate and both beads are
therefore bound intramolecularly, the system luminesces.
However, if CASP3 had cleaved the NCtagged PK,
luminescence is suppressed because the beads are no
longer in close contact. As a proof-of-concept experiment,
cleavage of the test PK, NCtagged PAK2, was assessed
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Figure 1 Schematics of the DNA template construction and the CASP3-substrate-screening assay. Protein kinase (PK) genes were obtained from the human MGC and
mouseFANTOMlibraries,andfromalibraryofPKgenesthatwehadcloned.ThePKgeneswerePCRampliﬁedwiththeFlagandthebiotinligationsite(bls)tagsaddedtothe
upstream and downstream ends, respectively. The modiﬁed genes were each inserted into a Gateway pDONR221 vector (pDONR-Flag-PK-bls) and DNA templates
(SP6-E02-Flag-PK-bls)wereconstructedbysplit-primerPCRandthenexpressedinthewheatcell-freeproteinsynthesissystemthatincludedbiotinligaseand D-biotintogive
Flag-PK-blsBbiotin constructs. The Flag and biotin tags were bound to protein A-conjugated acceptor beads via an anti-Flag antibody and streptavidin-conjugated donor
beads, respectively. An intact complex luminesced strongly, whereas after CASP3 cleavage and dissociation of the protein fragments, the luminescence was abolished
or reduced
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Cell Death and Diseaseusing this system. CASP3 treatment decreased the
luminescent signal to 19±7% that of the control (no CASP3;
Figure 2b). Therefore, the system could detect CASP3
cleavage and can replace conventional immunoblotting
procedures.
Screening of the CASP3-substrate kinome. Using the
luminescent system, 304 NCtagged PKs were screened. The
level of luminescence after CASP3 treatment is reported as
the percentage of the corresponding control (no CASP3;
Figure 2c and d). Thirteen of the NCtagged PKs for
which luminescence was low after CASP3 treatment are
known CASP3 substrates.
23,24,26 The smallest and largest
luminescent values were for STK4 (1%) and BMX (73%),
respectively; we therefore examined the physical states
of the PKs that had been treated with CASP3 and had
associated luminescence values of B80% by immuno-
blotting with anti-Flag antibodies and Alexa488-streptavidin
to detect the N- and C-termini of the NCtagged PKs,
respectively. This ‘terminal detection’ (TD) immunoblot
assay identiﬁed 43 NCtagged PKs that had been cleaved
(Supplementary Table S1). In addition to the 13 PKs
that were known to be CASP3 substrates, 30 previously
unidentiﬁed PK that were substrates of CASP3 were found
(Figure 3 and Table 1). In addition, because the apparent
molecular weights of the N- and C-terminal fragments could
be estimated from their positions in the TD immunoblot, the
CASP3 cleavage sites could be predicted (red arrowheads,
Figure 3). For MASTL, the signal on the immunoblot
with Alexa488-conjugated streptavidin was not detectable,
probably indicating that the efﬁciency of biotinylation in
MASTL proteins might be too low to detect for the
immunoblot. Luminescent signal of this clone was also very
low (see Supplementary Table S1).
A comparison of the luminescent and immunoblot data
correlated a luminescent signal of o78% with a positive
immunoblot result. Forty-eight PK constructs with lumines-
cent signals 478% were tested and returned negative
immunoblot results (Supplementary Table S1). Therefore, a
luminescent signal of B78% is the apparent divisor between
PKs that can be cleaved by CASP3 and those that cannot
be cleaved.
In vivo identiﬁcation of the PKs that were identiﬁed as
CASP3 substrates by the luminescent assay. We
investigated whether the newly identiﬁed PKs that were
substrates of CASP3 were cleaved in HeLa cells that
had been induced to undergo apoptosis by TNFa plus
cycloheximide (TNFa)
27 or anti-Fas antibody (anti-Fas).
28
The genes encoding these PKs were each inserted into the
transfection vector, pDEST26, using the Gateway system
and expressed as (His)6-PK-Flag constructs. We were able
to detect all expressed PK constructs, except DYRK3,
by immunoblotting with anti-(His)6 or anti-Flag antibodies.
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Figure 2 Screening of CASP3-cleaved PK substrates from the NCtagged PK library. (a) Immunoblot of NCtaggedPAK2 that had been incubated in the presence (þ)o r
absence ( ) of CASP3. Alexa488-labeled streptavidin (STA(C)) was used for detection. (b) Detection of CASP3-cleaved NCtagged PAK2 using the AlphaScreen system.
Theluminescencefor thecontrol (no CASP3) was set to 100%. The valueof 19%indicatedthat most of theNCtaggedPAK2was cleavedby CASP3.Each valueis the mean
of three independent experiments, and the uncertainty is reported as the standard deviation. (c) Luminescent signals remaining after in vitro CASP3 treatment of NCtagged
PKs that had been synthesized in the wheat cell-free system. The x axis lists the NCtagged PKs in ascending order of their luminescent signals after CASP3 treatment.
(d)NCtaggedPKsthatreturnedluminescentsignalsofo78%ofthecontrolvalues.Theplotcontainsthedataof(c)withinthegreenrectangle.RedbarsareforPKsthatwere
known to be substrates of CASP3 before this report
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Cell Death and DiseaseNotably, they were detected as cleavage products and/or
were found in smaller amounts when the cells had been
induced to undergo apoptosis than when apoptosis had been
inhibited by z-VAD-FMK (Figure 4a and b). Furthermore,
apoptosis-induced cleavage of four endogenous PKs was
found by immunoblotting with commercially available
antibodies against the endogenous PKs (Figure 4c). These
in vivo experiments validated the underlying concept of our
in vitro cell-free system as the in vivo system found all of
the PKs identiﬁed by the in vitro system.
Characterization of the CASP3 cleavage sites in the
newly identiﬁed PK substrates. We characterized
the CASP3 cleavage sites in the newly identiﬁed PK
substrates. As the positions of the cleaved PK fragments in
the TD immunoblot could be used to estimate the size of the
cleaved fragments and because the antibodies could be
used to identify whether the fragments were derived from the
N- or C-terminal regions of the PKs, we could predict the
approximate positions of the CASP3 cleavage sites (red
arrowheads, Figure 3). Each NCtagged PK that was a
substrate for CASP3 was synthesized in the cell-free system
and puriﬁed using Streptavidin Magnesphere Paramagnetic
beads. Their C-terminal fragments that bound to the beads
were recovered after CASP3 cleavage and their sequences
were determined. Using this approach, the cleavage sites
of ACVR1, AKT2, BMPR1B, CaMKK1, HSPB8, MAPK12,
MKNK2(D58), PDPK1, PRKCI, PRKX, RIOK1, RIOK3, and
RPS6KA5 were determined. We then attempted to determine
the cleavage sites of the remaining PKs by other methods.
The NCtagged PKs that had low biotin-labeling efﬁciencies
and were cleaved near their C-termini were genetically
modiﬁed by the addition of a glutathione-S-transferase
(GST) fragment at their C-termini to facilitate recovery with
Figure 3 In vitro cleavage of NCtagged PKs by CASP3. The NCtagged PKs that had been incubated in the presence (þ) or absence ( ) of CASP3 and their cleavage
products were detected using anti-Flag antibodies (FLAG(N)) and Alexa488-conjugated streptavidin (STA(C)), which bound to the N- and C-termini of the PK constructs,
respectively. The cartoons of the proteins that are under the lanes show the locations of the conserved domains (colored boxes) and the predicted cleavage sites
(red arrowheads). The conserved domains that are found in the Conserved Domains Database (http://www.ncbi.nlm.nih.gov/cdd) are: ACD, alpha-crystallin domain; activin,
conserveddomainforactivinmembers;ADF,actindepolymerization factor/coﬁlin-like domain;a-kinase,conservedkinasedomainforthea-kinasefamily;C1,phorbol esters/
diacylglycerol binding domain; DCX, doublecortin domain; death, death domain; GS, GS motif; KA1, kinase-associated domain; kinase, catalytic domain of protein kinase;
PB1, Phox and Bem1p domain; PH, pleckstrin homology domain; RIO, catalytic domain of eukaryotic RIO kinase family; SH2, src homology 2 domain; SH3, src homology 3
domain; UBL, ubiquitin-like domain
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Cell Death and Diseaseglutathione Sepharose 4B beads after CASP3 cleavage.
CASP3 cleavage of the PK-GSTs produced the same
size N-terminal fragments as those of the corresponding
CASP3-cleaved NCtagged PKs, indicating that the GST tags
did not alter the positions of the cleavage sites. In addition,
the sequences of the cleaved c-src tyrosine kinase (CSK)
and AMP-activated kinase-a1 (AMPKa1) fragments were
determined using MALDI/TOF-MS. Other PK constructs that
were synthesized in small amounts were subjected to D-A
mutagenesis to determine their cleavage sites. In total, 28
cleavage sites in 23 PKs were identiﬁed (Table 1). Identical or
similar cleavage sites were found inthe correspondinghuman
and mouse PKs, except for those of PRKX (Supplementary
Table S2). (Sequence analysis showed that mouse PRKX
does not have the N-terminal region that is found in human
PRKX.) Therefore, the CASP3-substrate kinome may be
highly conserved in mammals.
We also analyzed the common sequence attributes
among the 28 cleavage sites and found that CASP3
prefers the sequence, DXXDkG (Figure 5a). The consensus
PK cleavage site for CASP3 in the MEROPS database is
DXXDkX. In the NCtagged PK library, 208 of the 304 PKs
contain a DXXDX sequence. However, only 33 PKs were
cleaved by CASP3; therefore, to be cleaved by CASP3, the
DXXDX sequence and a structural element –probably
accessibility – are required.
Characterization of the newly identiﬁed PKs that were
cleaved near their N- or C-termini. Interestingly, 16 out of
the 23 PKs, for which cleavage sites were characterized,
have cleavage sites within 60 residues of their N- or
C-termini. We investigated whether these sites were
also cleaved in vivo when apoptosis was induced by TNFa.
For these experiments, CaMKK1, eEF2K, MNK2, AMPKa1,
and TRIB3, which were cleaved in vitro at D32, D14, D32/
D58, D520 (30 residues away from the C-terminus), and
D338 (20 residues away from the C-terminus), respectively,
were used (Figure 5b and Table 1). Their genes (wild type,
WT) were each reconstructed with a V5 tag added at the end
opposite the cleavage site. The genes for their D-A mutants
(DA), and for the sequences of their longer CASP3-cleaved
fragments (C3M), were also constructed and all were
expressed in control and in apoptotic cells (Figure 5c).
Cleavage of the WT PKs produced long fragments
corresponding to C3M in apoptotic cells, whereas z-VAD-
FMK blocked cleavage. These cleavages near the N- and
Table 1 Characteristics of the newly identiﬁed CASP3 PK substrates
Symbols Kinome
names
Groups Clone
origin
AA
a Cleavage
sequence
Cleavage
sites
Methods
b Conservation
c Smallest
frag.
d
In vivo
cleavages
e
ACVR1 ALK2 TKL Hs 509 IASDkM 269 NT Yes C240 Yes
AKT2 AKT2 AGC Mm 481 DAMDkY 121 NT Yes N121 Yes
BMPR1B ALK6 TKL Hs 502 CSTDkG 50 NT Yes N50 Yes
DFVDkG 120 NT Yes
CaMKK1 CaMKK1 Other Hs 520 EEADkG 32 NT Yes N32 Yes
CSK CSK TK Mm 450 DAPDkG 409 MS Yes C41 Yes
CSNK1G1 CK1g1 CK1 Mm 459 VHVDkS 343 MU Yes C116 Yes
eEF2K eEF2K Atypical Hs 725 EGVDkG 14 MU Yes N14 Yes
DHLDkN 430 MU Yes
HSPB8 H11 Atypical Hs 196 MADkG 3 NT Yes N3 Yes
MAP2K6 MAP2K6 STE Mm 334 DFVDkF 289 MU Yes C45 Yes
MAPK12 p38g CMGC Hs 367 SAVDkG 46 NT Yes N46 Yes
MARK1 MARK1 CAMK Hs 795 SATDkE 52 MU Yes N52 Yes
MKNK2 MNK2 CAMK Hs 414 DQPDkH 32 MU No N32 Yes
DIPDkA 58 NT Yes
PDPK1 PDK1 AGC Hs 556 SHPDkA 552 NT Yes C4 Yes
PIM2 PIM2 CAMK Hs 334 TDFDkG 198 MU Yes C113 Yes
PRKAA1 AMPKa1 CAMK Hs 550 TSLDkS 520 MS Yes C30 Yes
PRKCI aPKCi PKC Hs 596 TQRDkS 6 NT Yes N6 Yes
PRKX PRKX AGC Hs 358 ETPDkG 25 NT No N25 Yes
RIOK1 RIOK1 Atypical Mm 568 EKDDkI 37 NT Yes N37 Yes
RIOK3 RIOK3 Atypical Hs 516 DTRDkD 139 NT Yes N139 Yes
RPS6KA5 MSK1 AGC Hs 549 DGGDkG 20 NT Yes N20 Yes
DELDkV 344 NT Yes
TEMDkP 356 NT Yes
SNARK NuaK2 CAMK Hs 628 VSEDkS 546 MU Yes C82 Yes
TRIB3 TRB3 CAMK Hs 358 VVPDkG 338 NT Yes C20 Yes
ULK4 ULK4 Other Hs 580 SQIDkS 473 MU Yes C107 Yes
DCAMKL2 DCAMKL2 CAMK Hs 695 — — — — — Yes
DYRK3 DYRK3 CMGC Hs 568 — — — — — ND
IRAK2 IRAK2 TKL Mm 622 — — — — — Yes
MASTL MASTL AGC Hs 879 — — — — — Yes
PCTK1 PCTAIRE1 CMGC Hs 496 — — — — — Yes
PTK9 A6 Atypical Hs 384 — — — — — Yes
TGFBR1 TGFBR1 TKL Hs 426 — — — — — Yes
Abbreviations:Hs,humanclone; Mm,mouse clone;MS, massspectroscopy;MU, mutation; ND, not determined; NT,N-terminal sequencing.
aLength ofamino acids.
bMethods for determination of cleavage site.
cVery similar site conserving the Asp (D) of the hydrolytic bond was found between human and mouse PKs (Yes),
whereas no similar sites was done (No).
dThe smallest N (N) or C (C) fragment in the cleaved PKs. Number is the length of amino acids of the fragment.
eData from
Figure 4.
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Figure4 InvivocaspasecleavageofthenewlyidentiﬁedPKsubstratesandofendogenousPKsubstrates.(a)Invivocleavageofthe(His)6-PK-Flagconstructsexpressed
in apoptotic HeLa cells. The cells were treated with DMSO (control) or with TNFa and cycloheximide (TNFa) in the presence and absence of z-VAD-FMK (a CASP3 inhibitor)
for 6h and then lysed. The cell extracts were immunoblotted and the PK constructs were detected with anti-Flag antibodies, except for HSPB8 and MAP2K6. Anti-His tag
antibody was used for the two PKs. (b) The cells were transfected with a plasmid of (His)6-PK-Flag constructs, and treated with DMSO (control), or with anti-Fas antibody
(anti-Fas) in the presence and absence of z-VAD-FMK for 6h and then lysed. Immunoblotting was carried out as (a). (c) HeLa cells were treated as in (a), but were not
transfected with a (His)6-PK-Flag gene. Each endogenous PK was detected using an antibody speciﬁc for it. a-Tubulin was used as an internal marker
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Figure 5 The cleavage site logo and in vivo cleavage of ﬁve PKs that are cleaved by CASP3 near their N- or C-termini. (a) The 20 residues surrounding the D of the
hydrolytic bond in 28 PKs were analyzed using WebLogo, version 3.0.
36 (b) Cartoons of ﬁve PK sequences that have cleavage sites near their N- or C-termini. The
corresponding PKswereusedfortheexperimentshownin (c).Thepositionsof thealanines intheD-Amutants(DA)are shown,asare thelongfragments(C3M)produced
byCASP3cleavage.V5tagswerefusedattheendsfartherawayfromthecleavagesites.TheﬁrstMinC3MofCaMKK1,eEF2K,andMNK2indicatesamethionineasastart
amino acid. (c) Immunoblots of PK-V5s and V5-PKs that had been expressed in apoptotic HeLa cells. The cells were treated with DMSO (control) or with TNFa and
cycloheximideinthepresenceorabsenceofz-VAD-FMKfor6handthenlysed.Theproteinswereblottedandthendetectedwith anti-V5antibodies.WTindicatesawild-type
protein
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Cell Death and DiseaseC-termini of the PKs suggest that CASP3 cleavage may
regulate the activity level and/or cellular localization of the
PKs, rather than simply inactivate the kinases.
Discussion
In1995,PITSLRE,
29PKCd,
30andDNA-PKcs
31werereported
as the ﬁrst PK-type substrates of CASP3. During the next
15 years, 36 additional PKs that can be cleaved by CASP3
were found.
23,24,26 Notably, these authors showed that
CASP3-cleavedPKsabrogatesurvivalsignalsandaccelerate
apoptosis.Inthisstudy,weidentiﬁedanadditional30PKsthat
can be cleaved by CASP3. In addition, many of the cleavage
sites were found in regulatory elements or in the regions near
the N- and C-termini, rather than the kinase domain itself.
Some of the newly identiﬁed CASP3-substrate PKs may be
involved in apoptotic signal cascades. Sixteen PKs were
shown to be cleaved in vitro near their N- or C-termini and at
least ﬁve of them were also cleaved near their N- or C-termini
in apoptotic cells (Figure 5). Using standard immunoblotting,
proteins that are cleaved into a large and a small fragment
may be overlooked because the mobilities of the large
fragment and the intact protein will be nearly identical. Most
of the PKs that had been previously reported to be cleaved by
CASP3 were identiﬁed because the cleaved fragments had
very different molecular weights than did the intact PK and
were therefore easily detected by SDS-PAGE. Consequently,
cleavages near the termini may have been overlooked. Taken
together, our results suggest that CASP3 cleavage of some
of the members of the CASP3-substrate kinome alters the
function of the PKs and thereby signals apoptosis.
For the study reported herein, 304 out of 518 known PKs,
synthesized as NCtagged PKs, were subjected to the
in vitro cleavage assay (Supplementary Table S1). The
relative number of PKs that were cleaved was B14%. A total
of 69 PKs that are CASP3 substrates are now known, which
suggests that at least B13% of the PKs in the human kinome
are targets of CASP3. As B200 PKs have yet be tested as
CASP3substrates,anadditional26PKs(13%ofthe200)may
be CASP3 substrates. The human genome contains 518
annotatedPKs,whichhavebeendividedinto10groupsonthe
basis oftheir sequence homologies.
3Interestingly, the groups
differ in terms of their susceptibilities to CASP3 cleavage
(Table2).Approximately30%ofthePKsintheAGCgroupare
known CASP3 substrates, for example, AKT2, S6K, MSK,
PKC, and PDK1. Many of the AGC-type PKs are commonly
found in mammalian tissues,
32 and their cleavage sites are
located in their regulatory domains (Figure 4 and Table 1).
Therefore, these abundant PKs may be activated when
CASP3 cleaves them and then act as intracellular apoptosis
signals. Conversely, CASP3 cleaved only a relatively small
number (6B8%) of the PKs in the CMGC group, which
includes the kinases of the CDK and CDKL families, and the
tyrosine kinase groups. Therefore, most members of these
groups may only act indirectly as apoptosis signals after
CASP3 activation.
Such ROCK1 and MST1, certain caspase cleavage
products, work as apoptosis signaling.
23,24 In this study, we
found at least six new CASP3 cleavage products, derived
from AKT2, CaMKK1, eEF2K, MARK1, MNK2, and TRB3,
after 6h from apoptosis induction (Figures 4 and 5). These
cleavage products retain kinase domain, as in the case of
ROCK1 and MST1. On the other hand, we could not detect
any cleavage products from the other kinases in vivo. The
reasons are not yet understood. However, recent proteomics
approach has shown that the cleaved proteins displayed
transientfragmentsintheapoptoticcells.
12Furtheranalysisat
multiple time points during the apoptotic cascade would be
required for detection of the cleavage products from the
remaining PKs.
For TRIB3, full-length TRIB3 (D338A) mutant was
decreased in apoptotic condition (compared TNFa lane
with TNFa plus z-VAD-FMK lane in Figure 5c). However, the
mutant could not produce the CASP3 cleavage product found
as the shorter form in TNFa lane of WT, indicating that the
mutant was not cleaved by CASP3. The mutant was also not
cleaved by CASP3 in vitro (data not shown). As TRIB3 has
been known to receive proteasomal degradation,
33 this
unexpected reduction of the mutant TRIB3 in the apoptotic
cells may be the effects of cycloheximide and/or caspase-
inhibitor treatment on TRIB3 degradation.
Proteases often modify the activities of their targeted
protein substrates. Identiﬁcation of the speciﬁc substrate
that is cleaved by a protease is necessary if the functions of
both the protease and its substrate are to be understood.
Proteomic studies have used mass spectrometry to exhaus-
tively identify cellular proteins that have been cleaved
by proteases.
11,12 However, it has been difﬁcult to corre-
late speciﬁc proteases with their substrates because many
proteases act at the same time in vivo.
Many full-length cDNAs derived from the genes of higher
eukaryotes are available from many different sources. These
cDNAs are potentially a great DNA template resource for
in vitro syntheses of proteins. As a protein production
system and for the functional analysis of proteins, the wheat
cell-free system has many advantages: It can effectively use
PCR-generated DNA templates.
14 It is easily adapted to
an automated system.
15 It can be used to incorporate a single
label into target proteins.
20 Its synthesized proteins do not
require puriﬁcation before being assayed, and it has no
detectable proteasome activity.
21 In addition, the screening
cost is very low (BUS$1/assay), which for our study trans-
lated to 10 cents to produce each NCtagged protein and
Table 2 Characteristics of the protein kinases used in this study
Groups Total
a Tested
clones
Cleaved clones
(new
b)
Cleaved/test
clones (%)
AGC 63 33 10 (6) 30
CAMK 74 52 8 (7) 15
CK1 12 8 1 (1) 13
CMGC 61 39 3 (3) 8
Other 83 46 3 (2) 7
STE 47 25 4 (1) 16
TK 90 51 3 (1) 6
TKL 43 27 6 (4) 22
RGC 5 2 0 0
Atypicals 40 21 5 (5) 24
Total 518 304 43 (30) 14
aEach number is corresponding to human kinome.
bNewly PK numbers found in
this study.
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used in one assay.
In summary, we showed that an NCtagged PK library
synthesized in a cell-free system could be used to charac-
terize a CASP3-substrate kinome. Analysis of the
CASP3-cleavage sites indicated that CASP3 cleavage of
PKsdependsonbothprimaryandtertiarystructure.Almostall
of the PK substrates that we identiﬁed in vitro were also
identiﬁed in vivo. Systems similar to that used herein could be
used to screen other protease substrates.
Materials and Methods
General. The following procedures have been described:
14–16,20–22,34 wheat
cell-free protein production; split-primer PCR synthesis of the DNA templates;
parallel syntheses of mRNAs and their translated proteins; and measurements of
theamountsof protein synthesizedusing densitometer scansof Coomassiebrilliant
blue-stained proteins or of radiolabeled proteins.
Construction of DNA templates for the expression of a PK
protein library. The cloned genes encoding the PKs used in this study are
listed in Supplementary Table S1. Their open-reading frames (without stop codons)
were modiﬁed in two steps using PCR and the primers S1 (50-CCACCCACCAC
CACCAatg(n)16-30) and T1 (50-TCCAGCACTAGCTCCAGA(n)19-30) (lowercase
letters indicate nucleotides of the gene) for the ﬁrst step, and the primers
attB1-Flag-S1 (50-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGGACTACAAG
GATGACGATGACAAGCTCCACCCACCACCACCAATG-30) and T1-bls-STOP-
attB2-anti (50-GGGGACCACTTTGTACAAGAAAGCTGGGTTTATTCGTGCCACTC
GATCTTCTGGGCCTCGAAGATGTCGTTCAGGCCGCTTCCAGCACTAGCTCCA
GA-30) for the second step. The PCR-modiﬁed genes were each inserted into a
pDONR221 vector using the Gateway BP Clonase II enzyme mix (Invitrogen,
Carlsbad,CA,USA)togivepDONR-Flag-PK-blsvectors.Escherichiacolicellswere
transformed with these vectors and then cultured in wells of a 96-well plate that
contained GYT medium (10% (v/v) glycerol, 0.125% (w/v) yeast extract, and 0.25%
(w/v) tryptone) for 48h without shaking. DNA templates for mRNA and protein
expression were constructed using split-primer PCR
14 in two steps. For the ﬁrst
step, the pDONR221-Flag-PK-bls plasmids that had not been isolated from the
E. coli cells, and the primers pDONR221-1st_4080 (50-ATCTTTTCTACGGGGT
CTGA-30) and deSP6E02-Flag-S1 (50-GGTGACACTATAGAACTCACCTATCTC
TCTACACAAAACATTTCCCTACATACAACTTTCAACTTCCTATTATGGACTACAA
GGATGACGATGACAAGCTCCACCCACCACCACCAATG-30) were used, and for
the second step, the ampliﬁed sequences of the ﬁrst step and the primers SPu
(50-GGGTAGCATTTAGGTGACACT-30) and pDONR221-2nd_4035 (50-ACGTTAA
GGGATTTTGGTCA-30) were used to give SP6-E02-Flag-PK-bls DNA templates.
(The E02 sequence is a translational enhancer,
35 and the SP6 sequence is an
SP6 RNA polymerase promoter.)
Cell-freeproteinsynthesis. Cell-freeproteinsynthesisusedthereagentsof
an ENDEXT Wheat Germ Expression S Kit according to the manufacturer’s
instructions(CellFreeSciencesCo.,Ltd.),thebilayertranslationmethod,
15,16,34and
a robotic synthesizer (GenDecorder 1000; CellFree Sciences). Each DNA template
was transcribed by SP6 RNA polymerase, then precipitated with ethanol, and
collectedbycentrifugation (15000r.p.m.for5min.,R10H rotor;Hitachi).EachmRNA
(B30–35mg) was washed with 75% ethanol, added into a translation mixture, and
translated in the bilayer mode
31 with the following modiﬁcations. The translation
mixture (25ml) (bottom layer) contained 60 A260/ml of ENDEXT wheat germ extract,
1  SUB-AMIX (24mM Hepes-KOH, pH 7.8, 1.2mM ATP, 0.25mM GTP, 16mM
creatine phosphate, 2.5mM DTT, 0.4mM spermidine, 0.3mM each of the 20 amino
acids, 2.8mMmagnesium acetate,100mMpotassium acetate), 2mg creatine kinase
(Roche Applied Science, Indianapolis, IN, USA), 500nM D-biotin (Nacalai Tesque,
Kyoto,Japan),and1mlofthewheatcell-freetranslationalmixturethatexpressedBirA
biotin ligase (B50ng/ml, BirA: GenBank Accession No. NP_0312927). A 1  SUB-
AMIX solution (125ml) was placed over the translation mixture. The bilayer was
incubated at 261C for 17h to allow for protein synthesis. All steps including
construction of the DNA templates were performed in the wells of a 96-well plate.
Cleavage assay. The cell-free-synthesized PKs that had luminescent signals
4500 units (in the absence of CASP3) were studied. For each PK, 10ml of the
CASP3 cleavage buffer (20mM Tris-HCl, pH 7.5, 0.2mM DTT, 5mM MgCl2,3m M
ATP, 1mg/ml BSA, 1mU CASP3 (Sigma-Aldrich, St. Louis, MO, USA)) was mixed
with 1ml of the translation mixture that contained a Flag-PK-blsBbiotin construct,
and the mixture was incubated at 301C for 2h in a well of a 384-well Optiplate
(Perkin Elmer, Foster City, CA, USA). Using the reagents of an AlphaScreen IgG
(protein A) detection kit (Perkin Elmer) according to the manufacturer’s instructions,
15ml of 20mM Tris-HCl, pH 7.5, 0.2mM DTT, 5mM MgCl2,5mg/ml anti-FLAG M2
antibody (Sigma-Aldrich), 1mg/ml BSA, 0.1ml of streptavidin-coated donor beads
and 0.1ml of anti-IgG acceptor beads were added to the well. The solution was
incubated at 231C for 1h. Luminescence was analyzed using the AlphaScreen
detection program (Perkin Elmer). All repetitive mechanical procedures were
performed by a Biomek FX robotic workstation (Beckman Coulter, Fullerton, CA,
USA). The value of a luminescent signal is reported as the mean of three
independent measurements.
TD immunoblotting. A mixture of each Flag-PK-blsBbiotin construct (3mlo f
a translation mixture) and 7ml of the CASP3 cleavage solution was incubated at
301Cfor1hinawellof a384-wellOptiplate(PerkinElmer).Then,theproteinswere
separated in SDS-PAGE gels and transferred to PVDF membranes (Millipore
Bedford, MA, USA). The blotted proteins were prepared for detection using the
reagents of an ECL-Plus Western Blotting Detection System kit (GE Healthcare,
Piscataway, NJ, USA), anti-Flag M2 antibodies (Sigma-Aldrich) for N-TD, and
Alexa488-streptavidin (Invitrogen) for C-TD. The labeled proteins were visualized
using a Typhoon Imager (GE Healthcare) with a 532-nm laser and a 526-nm
emission ﬁlter or an ImageQuant LAS-4000mini CCD camera system (Fujiﬁlm).
Sequencing and other puriﬁcation procedures. When possible, long
biotinylated C-terminal fragments produced by CASP3 cleavage were recovered
attached to streptavidin beads, and then sequenced directly. When a PK construct
had a low biotin-labeling efﬁciency and was cleaved near its C-terminus, a new
construct was made by fusing the GST nucleotide sequence encoded in the
pEU-E01-Gateway-GST vector to the C-terminal codon of the corresponding PK
open-reading frame using the Gateway system and the pEU-E01-Gateway-GST
vector. For puriﬁcation, synthesized PKs (1.2ml) were puriﬁed using Streptavidin
Magnesphere Paramagnetic beads (Promega Corp., Madison, WI, USA) for the
Flag-PK-blsBbiotin constructs or glutathione Sepharose 4B (GE Healthcare) for
the PK-GST constructs. After washing the beads with PBS, the bound PKs were
incubated with CASP3 (15ml of total volume) as described above. The samples
were boiled and the proteins separated by SDS-PAGE. After blotting and
visualization (ProBlott, Applied Biosystems, Foster City, CA, USA), the membrane
areas that contained the cleaved fragments were cut out and the fragments were
sequenced (Applied Biosystems ABI 473A). CSK kinase (Carna Biosciences Inc.,
Kobe, Japan) and AMPKa1 (Cell Signaling Technology, Beverly, MA, USA) were
cleavedwith CASP3(10ml of totalvolume), and the cleavageproducts subjectedto
MALDI/TOF-MS (Shimazu Techno-Research Inc., Kyoto, Japan) for sequencing.
D-A mutagenesis was carried out using the reagents of a PrimeSTAR
Mutagenesis Basal kit (TakaraBio, Otsu, Japan) according to the manufacturer’s
instructions. The mutated genes were sequenced using an ABI PRISM 310 DNA
sequencer (Applied Biosystems).
Construction of PK expression plasmids for the cell-based
assay. Expression plasmids were produced using the Gateway method. To
obtain the attB1-PK-Flag-(stop codon)-attB2 for Gateway BP Clonase II recombi-
nation, the open-reading frame products of the 30 newly identiﬁed PK substrates of
CASP3 that had been produced by PCR using the S1 and T1 primers as described
above were PCR ampliﬁed using the primers, attB1-S1 (50-GGGGACAAGTTTGTA
CAAAAAAGCAGGCTTCCACCCACCACCACCA-30) and T1-Flag-stop-attB2
(50-GGGGACCACTTTGTACAAGAAAGCTGGGTTTACTTGTCATCGTCATCCTTG
TAGTCGCTTCCAGCACTAGCTCCAGA-30). These PCR products were each
inserted into a pDEST26 vector (Invitrogen) using the Gateway system for
construction of the His-PK-Flag nucleotide sequences. All sequences were
conﬁrmed by DNA sequencing as described above.
Cell-based assay. HeLa cells were cultured in Dulbecco’s modiﬁed Eagle’s
medium,10%fetalbovineserum,penicillin(100mg/ml),andstreptomycin(50mg/ml).
Transient transfections were carried out using Lipofectamine 2000 Transfection
Reagent (Invitrogen) according to the manufacturer’s instructions. At 24h after
transfection, cells were harvested after apoptosis was induced. Control cells were
treated with DMSO and, for apoptosis induction or inhibition, with 20ng/ml TNFa
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Cell Death and Disease(Calbiochem, La Jolla, CA, USA) and 100mM cycloheximide (Chemicon, Temecula,
CA,USA)or125ng/mlanti-Fasantibody(Medical& BiologicalLaboratoriesCo.,Ltd.,
Nagoya, Japan) inthe presence(inhibition)orabsence (induction) of100mMZ - V A D -
FMK (Peptide Institute Inc., Osaka, Japan) for 6h. Cells were washed with PBS and
then lysed directly by adding one volume of 2  SDS-PAGE sample buffer (125mM
Tris-HC1, pH 6.8, 20% glycerol, 4% SDS, 10% 2-mercaptoethanol, 0.001%
bromphenol blue) before subjecting the cell extracts to SDS-PAGE and
immunoblotting, which used anti-His antibodies (GE Healthcare) or anti-Flag M2
antibodies (Sigma-Aldrich). The following antibodies were employed to detect
endogenous proteins: anti-a-tubulin (Sigma-Aldrich); anti-AKT2, anti-eEF2K, anti-
AMPKa1, and anti-TGFbR1 (Cell Signaling Technology). Chemiluminescent signals,
generated by ECL-Plus reagents (GE Healthcare), or Immobilon Western HRP
substrate Luminol Reagent (Millipore), were detected using an LAS-4000mini
biomolecular imager (GE Healthcare).
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